Your Best Stock
Stocks › Top Retailers › CVS

CVS Health CVS

US equityMarket cap rank #143Top Retailers
$84.96
−$0.90 (-1.05%)
Market open · Sep 24, 2:00 pm ET
After hours $86.10 +0.28%
Open$85.80
Prev close$85.86
Day range$84.50 – $86.01
Volume3.49M
Market cap$108.66B
P/E (TTM)22.4
Dividend yield3.13%

Earnings

Average move on report day±5.1%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+14.9%
Worst reaction-16.8%

Stock move on the day after each report

-0.4%2023/Q3+3.1%2023/Q4-16.8%2024/Q1-3.2%2024/Q2+11.3%2024/Q3+14.9%2024/Q4+4.1%2025/Q1-0.3%2025/Q2-1.9%2025/Q3-0.1%2025/Q4+7.6%2026/Q1-5.1%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q25 Aug 2026Pre Market±5.8%-5.08%Within range
2026/Q16 May 2026Pre Market±4.7%+7.65%Bigger than priced
2025/Q410 Feb 2026Pre Market±4.1%-0.09%Within range
2025/Q329 Oct 2025Pre Market±4.0%-1.95%Within range
2025/Q231 Jul 2025Pre Market±4.9%-0.32%Within range
2025/Q11 May 2025–±4.1%+4.11%Within range
2024/Q412 Feb 2025Pre Market±4.6%+14.95%Bigger than priced
2024/Q36 Nov 2024Pre Market±4.5%+11.33%Bigger than priced
2024/Q27 Aug 2024Pre Market±4.8%-3.21%Within range
2024/Q11 May 2024Pre Market±3.3%-16.84%Bigger than priced
2023/Q47 Feb 2024Pre Market±3.5%+3.10%Within range
2023/Q31 Nov 2023Pre Market±3.4%-0.41%Within range
2023/Q22 Aug 2023Pre Market±3.5%+3.33%Within range
2023/Q13 May 2023Pre Market±3.4%-3.68%Bigger than priced
2022/Q48 Feb 2023Pre Market±3.3%+3.47%Bigger than priced
2022/Q32 Nov 2022Pre Market±4.3%+2.30%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Health services$51.80B 42.0%
  • Health Care Benefits$37.54B 30.4%
  • Pharmacy & Consumer Wellness$33.82B 27.4%
  • Corporate/other$147.00M 0.1%

Latest reported quarter: Q2, ended Jun 2026

Revenue$106.10B+7.3% YoY
Operating profit$4.70B+97.5% YoY
Net profit$3.00B+195.7% YoY
Diluted EPS$2.31+188.8% YoY
Free cash flow$5.65B+338.3% YoY
Operating cash flow$6.35B

Revenue, last 8 quarters

$95.4BSep '24$97.7BDec '24$94.6BMar '25$98.9BJun '25$102.9BSep '25$105.7BDec '25$100.4BMar '26$106.1BJun '26

Net profit, last 8 quarters

$71.0MSep '24$1.6BDec '24$1.8BMar '25$1.0BJun '25$-4.0BSep '25$2.9BDec '25$3.0BMar '26$3.0BJun '26

Profitability & balance sheet

Gross margin14.2%
Operating margin3.4%
Net margin1.2%
Return on equity6.2%
Return on assets1.9%
Return on invested capital4.8%
Current ratio0.87
Liabilities / assets68.5%
Cash & investments$13.96B
Total debt$74.39B
Net cash (debt)-$60.43B
Free cash flow / sales2.8%
Scroll to Top